Stay Informed

Sign up for news & alerts

Already signed up?
Login here
What Can I Do?


Get Help
Need alcohol or drug help for yourself or someone else? GET HELP
Resources
Resources
Find useful publications, online documents & more.


DrugScreening.org


 

Israeli Lawsuit Targets U.S. Cigarette Companies
June 27, 2000

Email
Email
Print
Print
SubscribeSubscribe
News Summary

A lawsuit against six U.S. tobacco companies and one Israeli company claims that cigarettes were made using naturally radioactive tobacco, Reuters reported June 22.

The suit was filed on behalf of Israel's Clalit national health fund, which represents 60 percent of Israelis. It seeks up to $8 billion from cigarette makers for allegedly poisoning and possibly irradiating Israelis.

The lawsuit cited an internal Philip Morris memo as evidence that the largest U.S. cigarette firm made cigarettes containing radioactive tobacco. The document was found in the Minnesota document archive that tobacco companies were forced to establish by U.S. court order.

"Whether the amount of radioactivity is harmful or not we don't know, but it is quite possible it is harmful because of the simple reason that nobody is checking," said attorney Amos Hausner. "Nobody, but nobody, assumes the risk of inhaling something radioactive."

The Clalit lawsuit is the biggesat in Israel's history.

COMMENTS ON THIS ARTICLE:

Your Turn! Post a public comment (guidelines):

Name:

Comment:
(limit 200
words)

Enter this word: Change

GUIDELINES:

  1. Keep it clean, courteous, non-commercial, and on-topic.

  2. Please do not post personal requests for help or personal contact information (Click here for help resources).

  3. Proof your comments carefully. They are published immediately and cannot be edited by you or by us.

  4. Making your post readable with careful spelling and punctuation will strengthen your point.  Don't use ALL CAPS.

We reserve the right to remove comments that do not conform to these guidelines (Report an inappropriate comment).

Have questions or feedback? Contact us.